Priority #5: Promoting the most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular disease.
Examples of Federal Initiatives Related to Priorities:
- CDC [Centers for Disease Control and Prevention] Community Transformation and Self Management Grants: In 2011, the Affordable Care Act provides $750 million in prevention and public health funding to support a variety of activities to promote healthy living. These grants represent a major commitment to promoting health in local communities, including reducing heart disease. Funding from CDC will support programs that reduce risk factors for chronic illnesses and discourage behaviors that increase risk.
- Focusing on Priority Conditions: The National Quality Strategy highlights cardiovascular disease as a place to start, partially out of recognition of other important efforts already under way. For example:
- The National HIV/AIDS Strategy: On July 13, 2010, the White House released the National HIV/AIDS Strategy (NHAS). This ambitious plan is the Nation's first-ever comprehensive coordinated HIV/AIDS roadmap with clear and measurable targets to be achieved by 2015. http://www.aids.gov/federal-resources/policies/national-hiv-aids-strategy
- The Strategic Framework on Multiple Chronic Conditions: In December 2010, HHS issued its new Strategic Framework on Multiple Chronic Conditions—an innovative, private-public sector collaboration. http://www.hhs.gov/ash/initiatives/mcc/
Initial Goals, Opportunities for Success, and Illustrative Measures:
Goal: Prevent and reduce the harm caused by cardiovascular disease.
Opportunities for success:
- Increase blood pressure control in adults.
- Reduce high cholesterol levels in adults.
- Increase the use of aspirin to prevent cardiovascular disease.
- Decrease smoking among adults and adolescents.
- Percentage of patients ages 18 years and older with ischemic vascular disease whose most recent blood pressure during the measurement year is <140/90 mm Hg.
- Percentage of patients with ischemic vascular disease whose most recent low-density cholesterol is <100.
- Percentage of patients with ischemic vascular disease who have documentation of use of aspirin or other antithrombotic during the 12-month measurement period.